Cargando…
Cross-Validation of the Taiwan Version of the Moorehead–Ardelt Quality of Life Questionnaire II with WHOQOL and SF-36
BACKGROUND: Obesity has become a major worldwide public health issue. There is a need for tools to measure patient-reported outcomes. The Moorehead–Ardelt Quality of Life Questionnaire II (MA II) contains six items. The objective of this study was to translate the MA II into Chinese and validate it...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950928/ https://www.ncbi.nlm.nih.gov/pubmed/19255812 http://dx.doi.org/10.1007/s11695-009-9813-y |
_version_ | 1782187668565655552 |
---|---|
author | Chang, Chi-Yang Huang, Chih-Kun Chang, Yu-Yin Tai, Chi-Ming Lin, Jaw-Town Wang, Jung-Der |
author_facet | Chang, Chi-Yang Huang, Chih-Kun Chang, Yu-Yin Tai, Chi-Ming Lin, Jaw-Town Wang, Jung-Der |
author_sort | Chang, Chi-Yang |
collection | PubMed |
description | BACKGROUND: Obesity has become a major worldwide public health issue. There is a need for tools to measure patient-reported outcomes. The Moorehead–Ardelt Quality of Life Questionnaire II (MA II) contains six items. The objective of this study was to translate the MA II into Chinese and validate it in patients with morbid obesity. METHODS: The MA II was translated into Chinese and back-translated into English by two language specialists to create the Taiwan version, which was validated by correlations with two other generic questionnaires of health-related quality of life (HRQOL), Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36), and World Health Organization Quality of Life (WHOQOL)-BREF Taiwan version. The convergent validity was accomplished by a series of Spearman rank correlations. Reliability of the MA II Taiwan version was determined by internal consistency obtained by Cronbach’s alpha coefficient and test–retest reliability obtained by intraclass correlation coefficient. RESULTS: One hundred subjects with morbid obesity were enrolled to test the MA II Taiwan version convergent validity and internal consistency. Test–retest studies (2 weeks apart) were applied to 30 morbidly obese patients. Satisfactory internal consistency was demonstrated by a Cronbach’s alpha coefficient of 0.79. Good test–retest reliability was shown by intraclass correlations ranging from 0.73 to 0.91. The total sum of MA II scores was significantly correlated with all four domains of the WHOQOL-BREF and two major components of SF-36 (all correlations, p < 0.01; range, 0.44–0.64). All six MA II items showed significant correlations with each other (r = 0.34–0.69, p < 0.01), and the total sum of MA II scores was negatively correlated with body mass index (r = −0.31, p < 0.01), indicating a one-dimensional questionnaire of HRQOL. CONCLUSIONS: The MA II Taiwan version is an obesity-specific questionnaire for QOL evaluation with satisfactory reliability and validity. It has the advantages of extensive evaluation for HRQOL, cross-cultural application, rapid completion, high response rates, and an advanced scoring system. |
format | Text |
id | pubmed-2950928 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-29509282010-10-21 Cross-Validation of the Taiwan Version of the Moorehead–Ardelt Quality of Life Questionnaire II with WHOQOL and SF-36 Chang, Chi-Yang Huang, Chih-Kun Chang, Yu-Yin Tai, Chi-Ming Lin, Jaw-Town Wang, Jung-Der Obes Surg Research Article BACKGROUND: Obesity has become a major worldwide public health issue. There is a need for tools to measure patient-reported outcomes. The Moorehead–Ardelt Quality of Life Questionnaire II (MA II) contains six items. The objective of this study was to translate the MA II into Chinese and validate it in patients with morbid obesity. METHODS: The MA II was translated into Chinese and back-translated into English by two language specialists to create the Taiwan version, which was validated by correlations with two other generic questionnaires of health-related quality of life (HRQOL), Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36), and World Health Organization Quality of Life (WHOQOL)-BREF Taiwan version. The convergent validity was accomplished by a series of Spearman rank correlations. Reliability of the MA II Taiwan version was determined by internal consistency obtained by Cronbach’s alpha coefficient and test–retest reliability obtained by intraclass correlation coefficient. RESULTS: One hundred subjects with morbid obesity were enrolled to test the MA II Taiwan version convergent validity and internal consistency. Test–retest studies (2 weeks apart) were applied to 30 morbidly obese patients. Satisfactory internal consistency was demonstrated by a Cronbach’s alpha coefficient of 0.79. Good test–retest reliability was shown by intraclass correlations ranging from 0.73 to 0.91. The total sum of MA II scores was significantly correlated with all four domains of the WHOQOL-BREF and two major components of SF-36 (all correlations, p < 0.01; range, 0.44–0.64). All six MA II items showed significant correlations with each other (r = 0.34–0.69, p < 0.01), and the total sum of MA II scores was negatively correlated with body mass index (r = −0.31, p < 0.01), indicating a one-dimensional questionnaire of HRQOL. CONCLUSIONS: The MA II Taiwan version is an obesity-specific questionnaire for QOL evaluation with satisfactory reliability and validity. It has the advantages of extensive evaluation for HRQOL, cross-cultural application, rapid completion, high response rates, and an advanced scoring system. Springer-Verlag 2009-03-03 2010 /pmc/articles/PMC2950928/ /pubmed/19255812 http://dx.doi.org/10.1007/s11695-009-9813-y Text en © The Author(s) 2009 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Research Article Chang, Chi-Yang Huang, Chih-Kun Chang, Yu-Yin Tai, Chi-Ming Lin, Jaw-Town Wang, Jung-Der Cross-Validation of the Taiwan Version of the Moorehead–Ardelt Quality of Life Questionnaire II with WHOQOL and SF-36 |
title | Cross-Validation of the Taiwan Version of the Moorehead–Ardelt Quality of Life Questionnaire II with WHOQOL and SF-36 |
title_full | Cross-Validation of the Taiwan Version of the Moorehead–Ardelt Quality of Life Questionnaire II with WHOQOL and SF-36 |
title_fullStr | Cross-Validation of the Taiwan Version of the Moorehead–Ardelt Quality of Life Questionnaire II with WHOQOL and SF-36 |
title_full_unstemmed | Cross-Validation of the Taiwan Version of the Moorehead–Ardelt Quality of Life Questionnaire II with WHOQOL and SF-36 |
title_short | Cross-Validation of the Taiwan Version of the Moorehead–Ardelt Quality of Life Questionnaire II with WHOQOL and SF-36 |
title_sort | cross-validation of the taiwan version of the moorehead–ardelt quality of life questionnaire ii with whoqol and sf-36 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950928/ https://www.ncbi.nlm.nih.gov/pubmed/19255812 http://dx.doi.org/10.1007/s11695-009-9813-y |
work_keys_str_mv | AT changchiyang crossvalidationofthetaiwanversionofthemooreheadardeltqualityoflifequestionnaireiiwithwhoqolandsf36 AT huangchihkun crossvalidationofthetaiwanversionofthemooreheadardeltqualityoflifequestionnaireiiwithwhoqolandsf36 AT changyuyin crossvalidationofthetaiwanversionofthemooreheadardeltqualityoflifequestionnaireiiwithwhoqolandsf36 AT taichiming crossvalidationofthetaiwanversionofthemooreheadardeltqualityoflifequestionnaireiiwithwhoqolandsf36 AT linjawtown crossvalidationofthetaiwanversionofthemooreheadardeltqualityoflifequestionnaireiiwithwhoqolandsf36 AT wangjungder crossvalidationofthetaiwanversionofthemooreheadardeltqualityoflifequestionnaireiiwithwhoqolandsf36 |